Study links acid-reducing drugs to increased risk of migraine

People who take acid-reducing drugs may have a higher risk of migraine and other severe headache than people who do not take these medications, according to a study published in the April 24, 2024, online issue of Neurology Clinical Practice, an official journal of the American Academy of Neurology.

Biogen nabs FDA approval for its biosimilar of arthritis and Covid-19 drug Actemra

Biogen scored an approval from the FDA for its biosimilar of Roche’s treatment Actemra on Friday, marking the first biosimilar of the drug to be

October 3, 2023

Minister for Science champions partnerships with private clinical sector in UK – Pharmaceutical Technology

Minister for Science Lord Vallance said Labour seek closer ties with commercial clinical industry to ignite innovation. Credit: Frankie Fattorini/GlobalData Lord Patrick Vallance has emphasised

November 7, 2024

How a for-profit health system’s push to expand ended in disappointment for a tiny island nation

Protesters in the tiny Mediterranean nation of Malta converged last October on the 18th-century Baroque palace housing the prime minister’s offices chanting “thieves,” and unfurled a

March 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.